Published mark
Nexalin Technology, Inc.
NASDAQ: NXL. Canonical company identity and public leadership record.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:79fcc1aa-4850-43fa-b580-af66746c46d9
- SEC CIK
- 0001527352
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 18, 2026
- Newest evidence
- Mar 25, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Mark WhiteSince Mar 25, 2026
- Chair
- Not published
- Independent
- 3 / 55 directors published
- Published claims
- 223 distinct sources
- Evidence records
- 70 pinned
- Source conflicts
- 0None open
Built from 3 distinct sources and 7 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
EXECUTIVE APPOINTED
Carolyn Shelton executive of Nexalin Technology, Inc., effective 2026-03-25.
EffectiveEffective Mar 25, 2026E3
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Senior Vice President of Quality, Clinical and Regulatory | Carolyn Shelton | Mar 2026 | current | Source reportedE3 |
| Chief Medical Officer, Director | David Owens | Mar 2026 | current | Source reportedE4 |
| Chief Financial Officer | Justin Van Fleet | Mar 2026 | current | Source reportedE5 |
| President, Chief Executive Officer, Director | Mark White | Mar 2026 | current | Source reportedE6 |
Board of directors
Evidence5 directors published. 3 of 5 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Alan Kazden | Independent | 2019 | AuditAudit; Compensation · Chair; Nominating and GovernanceCompensation, chairNominating and Governance | Source reportedE2 |
| Ben V. Hu, M.D. | Independent | 2022 | None published | Source reportedE2 |
| David Owens, M.D. | Not independent | 2022 | None published | Source reportedE2 |
| Leslie Bernhard | Independent | 2023 | Audit, chairAudit · Chair; Compensation; Nominating and Governance · ChairCompensationNominating and Governance, chair | Source reportedE2 |
| Mark White | Not independent | 2022 | None published | Source reportedE2 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Leslie Bernhard | Leslie Bernhard, Alan Kazden | Not described in the published record |
| Audit · Chair; Compensation; Nominating and Governance · Chair | Not published | Leslie Bernhard | Not described in the published record |
| Audit; Compensation · Chair; Nominating and Governance | Not published | Alan Kazden | Not described in the published record |
| Compensation | Alan Kazden | Alan Kazden, Leslie Bernhard | Not described in the published record |
| Nominating and Governance | Leslie Bernhard | Leslie Bernhard, Alan Kazden | Not described in the published record |
Committee RecordAudit: Chair Leslie Bernhard; Members Leslie Bernhard (Chair); Alan Kazden
Committee AppointmentLeslie Bernhard: chair, Audit
Committee AppointmentAlan Kazden: member, Audit
Committee RecordCompensation: Chair Alan Kazden; Members Alan Kazden (Chair); Leslie Bernhard
Committee AppointmentAlan Kazden: chair, Compensation
Committee AppointmentLeslie Bernhard: member, Compensation
Committee RecordNominating and Governance: Chair Leslie Bernhard; Members Leslie Bernhard (Chair); Alan Kazden
Committee AppointmentLeslie Bernhard: chair, Nominating and Governance
Committee AppointmentAlan Kazden: member, Nominating and Governance
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerMark White, President, Chief Executive Officer, Director, from Mar 25, 2026
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceSecurity ListingNXL (NASDAQ)
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 18, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameNexalin Technology, Inc.
Entity StatusPublic listing published
Published FactUS
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Carolyn SheltonSenior Vice President of Quality, Clinical and Regulatorycompany:79fcc1aa-4850-43fa-b580-af66746c46d9:leadership_role:10
- David OwensChief Medical Officer, Directorcompany:79fcc1aa-4850-43fa-b580-af66746c46d9:leadership_role:11
- Justin Van FleetChief Financial Officercompany:79fcc1aa-4850-43fa-b580-af66746c46d9:leadership_role:12
- Mark WhitePresident, Chief Executive Officer, Directorcompany:79fcc1aa-4850-43fa-b580-af66746c46d9:leadership_role:13, company:79fcc1aa-4850-43fa-b580-af66746c46d9:leadership_role:9
- Alan KazdenDirectorcompany:79fcc1aa-4850-43fa-b580-af66746c46d9:leadership_role:5
- Ben V. Hu, M.D.Directorcompany:79fcc1aa-4850-43fa-b580-af66746c46d9:leadership_role:6
- David Owens, M.D.Directorcompany:79fcc1aa-4850-43fa-b580-af66746c46d9:leadership_role:7
- Leslie BernhardDirectorcompany:79fcc1aa-4850-43fa-b580-af66746c46d9:leadership_role:8
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 7 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 18, 2026. Cited by 4 Claims.
- E2sec proxy. Published Jun 17, 2025. Retrieved Apr 28, 2026. Cited by 5 Claims.
- E3sec filing. Published Mar 25, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E4sec filing. Published Mar 25, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E5sec filing. Published Mar 25, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E6sec filing. Published Mar 25, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E7board_seats. board seats. Cited by 9 Claims.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 18, 2026- Carolyn Shelton executive of Nexalin Technology, Inc., effective 2026-03-25.
- David Owens executive of Nexalin Technology, Inc., effective 2026-03-25.
- Justin Van Fleet executive of Nexalin Technology, Inc., effective 2026-03-25.
- Mark White executive of Nexalin Technology, Inc., effective 2026-03-25.
- Leslie Bernhard seat on Nexalin Technology, Inc., effective 2023-01-01.
- Audit · Chair; Compensation; Nominating and Governance · Chair committee of Nexalin Technology, Inc., effective 2023-01-01.
- Leslie Bernhard member of Audit · Chair; Compensation; Nominating and Governance · Chair, effective 2023-01-01.
- Ben V. Hu, M.D. seat on Nexalin Technology, Inc., effective 2022-01-01.
- David Owens, M.D. seat on Nexalin Technology, Inc., effective 2022-01-01.
- Mark White seat on Nexalin Technology, Inc., effective 2022-01-01.
- Alan Kazden seat on Nexalin Technology, Inc., effective 2019-01-01.
- Audit; Compensation · Chair; Nominating and Governance committee of Nexalin Technology, Inc., effective 2019-01-01.
- Alan Kazden member of Audit; Compensation · Chair; Nominating and Governance, effective 2019-01-01.